Yuching Yang

2.0k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Yuching Yang is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Yuching Yang has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Infectious Diseases. Recurrent topics in Yuching Yang's work include Pharmacogenetics and Drug Metabolism (13 papers), Pharmaceutical studies and practices (9 papers) and Statistical Methods in Clinical Trials (6 papers). Yuching Yang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Pharmaceutical studies and practices (9 papers) and Statistical Methods in Clinical Trials (6 papers). Yuching Yang collaborates with scholars based in United States, Taiwan and Saudi Arabia. Yuching Yang's co-authors include Xinyuan Zhang, Yaning Wang, Shiew‐Mei Huang, Manuela Grimstein, Joseph A. Grillo, Issam Zineh, Brett A. Howell, Jianghong Fan, Hao Zhu and Kao‐Jean Huang and has published in prestigious journals such as The Journal of Immunology, Clinical Infectious Diseases and Clinical Cancer Research.

In The Last Decade

Yuching Yang

32 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration’s Office of Clinical Pharmacology

2018 241 citations Manuela Grimstein, Yuching Yang et al. Journal of Pharmaceutical Sciences profile →

Peers

Countries citing papers authored by Yuching Yang

Since Specialization

Citations

This map shows the geographic impact of Yuching Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuching Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuching Yang more than expected).

Fields of papers citing papers by Yuching Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuching Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuching Yang. The network helps show where Yuching Yang may publish in the future.

Co-authorship network of co-authors of Yuching Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuching Yang. A scholar is included among the top collaborators of Yuching Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuching Yang. Yuching Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Considerations for Regulatory Reusability of Dynamic Tools in the New Drug Development 2025 ·Pharmaceutical Research ·Jiang Liu, Yuching Yang, Jogarao Gobburu, Cynthia J. Musante, Martin Klein, Liang Zhao, Rajanikanth Madabushi, Hao Zhu	3
2	Landscape of regulatory quantitative systems pharmacology submissions to the U.S. Food and Drug Administration: An update report 2024 ·CPT Pharmacometrics & Systems Pharmacology ·Jane P. F. Bai, (unknown), Miao Zhao, Jie Wang, (unknown), (unknown), Justin Earp, Yuching Yang, Jiang Liu, Hao Zhu, Gilbert J. Burckart	7
3	Model‐Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory Perspective 2023 ·The Journal of Clinical Pharmacology ·(unknown), Li Wang, Jiang Liu, Justin Earp, Yuching Yang, Jingyu Yu, (unknown), Youwei Bi, Atul Bhattaram, Hao Zhu	0
4	Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Abdullah Al Shoyaib, Arian Emami Riedmaier, (unknown), Partha Pratim Roy, Neil Parrott, Lanyan Fang, Nilufer Tampal, Yuching Yang, (unknown), Liang Zhao, Fang Wu	11
5	FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement 2022 ·Clinical Cancer Research ·(unknown), Leigh Marcus, M. Naomi Horiba, Martha Donoghue, (unknown), Pallavi S. Mishra‐Kalyani, Robert N. Schuck, (unknown), Xinyuan Zhang, Jeanne Fourie Zirkelbach, Rosane Charlab, (unknown), Yuching Yang, Steven J. Lemery, Richard Pazdur, Marc R. Theoret, Lola A. Fashoyin‐Aje	33
6	FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies 2022 ·Genetics in Medicine ·Mari Suzuki, Linda Jo Bone Jeng, (unknown), Yan Wang, (unknown), (unknown), Jie Wang, Ruo‐Jing Li, Lian Ma, Yuching Yang, Xinyuan Zhang, (unknown), Ke Zhang, (unknown), (unknown), (unknown), Michael Pacanowski, Patroula Smpokou, Kathleen Donohue, Hylton V. Joffe	20
7	Integration of Engineered Delivery with the Pharmacokinetics of Medical Candidates via Physiology-Based Pharmacokinetics 2022 ·Methods in molecular biology ·Yuching Yang, Xinyuan Zhang	1
8	Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations 2021 ·CPT Pharmacometrics & Systems Pharmacology ·Xinyuan Zhang, Yuching Yang, Manuela Grimstein, (unknown), (unknown), Jianghong Fan, Ying‐Hong Wang, Justin Earp, James L. Weaver, Hao Zhu, Jiang Liu, Kellie S. Reynolds, Shiew‐Mei Huang, Yaning Wang	13
9	Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus 2021 ·Journal of Biomedical Science ·Yiyin Chen, Ching‐Tai Huang, Shiao-Wen Li, Yi‐Jiun Pan, Tzu-Lung Lin, Yayu Huang, (unknown), Yuching Yang, Yu‐Nong Gong, Yu‐Chia Hsieh	6
10	Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction 2021 ·Clinical Pharmacology & Therapeutics ·Jianghong Fan, Yuching Yang, Manuela Grimstein, Xinyuan Zhang, (unknown), Justin Earp, Vikram Arya, Kellie S. Reynolds, Hao Zhu, Yaning Wang	16
11	Synthetic Naphthofuranquinone Derivatives Are Effective in Eliminating Drug-Resistant Candida albicans in Hyphal, Biofilm, and Intracellular Forms: An Application for Skin-Infection Treatment 2020 ·Frontiers in Microbiology ·Jia‐You Fang, Kaiwei Tang, Sien‐Hung Yang, Ahmed Alalaiwe, Yuching Yang, Chih-Hua Tseng, Shih-Chun Yang	9
12	Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018‐2019 Submissions to the US FDA's Office of Clinical Pharmacology 2020 ·The Journal of Clinical Pharmacology ·Xinyuan Zhang, Yuching Yang, Manuela Grimstein, Jianghong Fan, Joseph A. Grillo, Shiew‐Mei Huang, Hao‐Jie Zhu, Yaning Wang	138
13	<p>The Droplet-Size Effect Of Squalene@cetylpyridinium Chloride Nanoemulsions On Antimicrobial Potency Against Planktonic And Biofilm MRSA</p> 2019 ·International Journal of Nanomedicine ·Jia‐You Fang, Yin‐Ku Lin, Pei‐Wen Wang, Ahmed Alalaiwe, Yuching Yang, Shih-Chun Yang	29
14	Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation 2019 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Yuching Yang, Xinyuan Zhang, Jeffry Florian, Hao Zhu, Million A. Tegenge, Shiew‐Mei Huang, Yaning Wang, Tina Morrison, Issam Zineh	112
15	Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration’s Office of Clinical Pharmacology breakdown → 2018 ·Journal of Pharmaceutical Sciences ·Manuela Grimstein, Yuching Yang, Xinyuan Zhang, Joseph A. Grillo, Shiew‐Mei Huang, Issam Zineh, Yaning Wang	241
16	An Analysis of N-Acetylcysteine Treatment for Acetaminophen Overdose Using a Systems Model of Drug-Induced Liver Injury 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Jeffrey L. Woodhead, Brett A. Howell, Yuching Yang, Alison H. Harrill, Harvey J. Clewell, Melvin E. Andersen, Scott Q. Siler, Paul B. Watkins	63
17	In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI 2012 ·Journal of Pharmacokinetics and Pharmacodynamics ·Brett A. Howell, Yuching Yang, Rukmini Kumar, Jeffrey L. Woodhead, Alison H. Harrill, Harvey J. Clewell, Melvin E. Andersen, Scott Q. Siler, Paul B. Watkins	74
18	A retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept. 2011 ·PubMed ·Sejal Shah, (unknown), Yuching Yang, Seth R. Stevens, Andrew Alexis	30
19	Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. 2008 ·PubMed ·Leon Kircik, Jerry Bagel, Neil J. Korman, Alan Menter, Craig A. Elmets, John Koo, Yuching Yang, (unknown), Frank Dann, Seth R. Stevens, (unknown)	60
20	The Dual-Specific Binding of Dengue Virus and Target Cells for the Antibody-Dependent Enhancement of Dengue Virus Infection 2006 ·The Journal of Immunology ·Kao‐Jean Huang, Yuching Yang, Yee‐Shin Lin, Jyh-Hsiung Huang, Hsiao‐Sheng Liu, Trai‐Ming Yeh, Shun‐Hua Chen, Huan‐Yao Lei	150

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact